Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00256698 · BASELINE

Baseline characteristics

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy · Source last updated 2012-08-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      258
    2. group Id
      BG001
      value
      256
    3. group Id
      BG002
      value
      514
    units
    Participants
groups
  1. description
    Fulvestrant 250 mg Loading Dose Regimen + Anastrozole 1 mg
    id
    BG000
    title
    Fulvestrant + Anastrozole
  2. description
    Anastrozole 1 mg
    id
    BG001
    title
    Anastrozole
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.6
          value
          65.2
        2. group Id
          BG001
          spread
          10.3
          value
          63.4
        3. group Id
          BG002
          spread
          10.0
          value
          64.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          258
        2. group Id
          BG001
          value
          256
        3. group Id
          BG002
          value
          514
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      258
    2. group Id
      BG001
      value
      256
    3. group Id
      BG002
      value
      514
    units
    Participants
groups
  1. description
    Fulvestrant 250 mg Loading Dose Regimen + Anastrozole 1 mg
    id
    BG000
    title
    Fulvestrant + Anastrozole
  2. description
    Anastrozole 1 mg
    id
    BG001
    title
    Anastrozole
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          9.6
          value
          65.2
        2. group Id
          BG001
          spread
          10.3
          value
          63.4
        3. group Id
          BG002
          spread
          10.0
          value
          64.3
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          258
        2. group Id
          BG001
          value
          256
        3. group Id
          BG002
          value
          514
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          0
        2. group Id
          BG001
          value
          0
        3. group Id
          BG002
          value
          0
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice